Tag: Drug Safety
Most Safety Signals Reported to FDA Lead to Regulatory Action
Regulatory actions by the FDA were corroborated by at least one relevant published research study for 17 of 57 resolved safety signals
Many Psychiatric Patients Are Getting Risky Drug Gabapentin ‘Off-Label’
By Amy Norton HealthDay Reporter
MONDAY, Nov. 22, 2021 (HealthDay News) -- Most prescriptions for the medication gabapentin are for unapproved uses -- and many...
About One in 20 Patients Exposed to Preventable Harm
Pooled prevalence of preventable patient harm was 6 percent; 12 percent was severe, led to death
PPI Use for Up to Three Years Safe During Anticoagulant Tx
Safety profile did not differ for pantoprazole versus placebo except greater risk for enteric infections
FDA: Higher Risk for Death Found With Venclexta in Multiple Myeloma
Enrollment suspended for trials investigating Venclexta for treatment of multiple myeloma
Bill to Fight U.S. Opioid Crisis Signed Into Law
Legislation expands treatment options, removes ban on Medicaid reimbursement at certain facilities
Testosterone Prescribing Down Since 2013
Decline coincided with reports linking testosterone to adverse cardiovascular events
International Group Develops Best Practices for Drug Packaging
Global regulators recommend adoption of ready-to-use/administer syringes and premixed IV solutions
Prescription-Strength Steroids Sold Without Prescription
Case report highlights Funbact-A, available online, which contains prescription-strength betamethasone
Postmarket Safety Events for 32 Percent of Novel Therapeutics
Thirty-two percent of 222 FDA approved novel therapeutics from 2001 to 2010 were affected
